<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.rcuk.ac.uk/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB"><gtr:id>1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB</gtr:id><gtr:name>National Institute for Medical Research</gtr:name><gtr:address><gtr:line1>Ocean Road</gtr:line1><gtr:line2>PO Box 9653</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/F11E21C9-E05F-4173-939C-61F868FE1FBA"><gtr:id>F11E21C9-E05F-4173-939C-61F868FE1FBA</gtr:id><gtr:name>The Wellcome Trust Ltd</gtr:name><gtr:address><gtr:line1>215 Euston Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>NW1 2BE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E9066440-7923-4DA5-9C32-D4A1055C7DA6"><gtr:id>E9066440-7923-4DA5-9C32-D4A1055C7DA6</gtr:id><gtr:name>Cipla</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/9218106A-E8CE-46A5-AABC-B4C8ED148690"><gtr:id>9218106A-E8CE-46A5-AABC-B4C8ED148690</gtr:id><gtr:name>University of Amsterdam</gtr:name><gtr:address><gtr:line1>Liaison Office</gtr:line1><gtr:line2>PO Box 19268</gtr:line2><gtr:line4>Amsterdam</gtr:line4><gtr:line5>Amsterdam</gtr:line5><gtr:postCode>1000 GG</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/ABE644D6-BBB8-44F3-96AA-6F49F0964577"><gtr:id>ABE644D6-BBB8-44F3-96AA-6F49F0964577</gtr:id><gtr:name>KEMRI-Wellcome Trust Research Programme</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/885DF811-29D2-42F7-AB4C-5857ED774495"><gtr:id>885DF811-29D2-42F7-AB4C-5857ED774495</gtr:id><gtr:name>Mbale Regional Hospital</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/1CD49681-075D-4AB9-A644-ED328E7C8D3A"><gtr:id>1CD49681-075D-4AB9-A644-ED328E7C8D3A</gtr:id><gtr:name>Malaria Consortium Africa, Kampala</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/5B1DAD82-5850-4A1E-8E7C-848FBC0A8F82"><gtr:id>5B1DAD82-5850-4A1E-8E7C-848FBC0A8F82</gtr:id><gtr:name>Spectral Diagnostics Inc</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/8446A993-B4C4-4CF7-8C31-B7F7566AA246"><gtr:id>8446A993-B4C4-4CF7-8C31-B7F7566AA246</gtr:id><gtr:name>University of Malawi</gtr:name><gtr:address><gtr:line1>P.O. Box 278</gtr:line1><gtr:line4>Zomba</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Malawi</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/76119A17-D4F8-4258-80F0-C8B307FFFA52"><gtr:id>76119A17-D4F8-4258-80F0-C8B307FFFA52</gtr:id><gtr:name>Radboud University Nijmegen</gtr:name><gtr:address><gtr:line1>Radboud University Nijmegen</gtr:line1><gtr:line2>PO Box 9102</gtr:line2><gtr:line4>Nijmegen</gtr:line4><gtr:postCode>6500 HC</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/E46289C2-E04C-4944-A440-310B8388DEEF"><gtr:id>E46289C2-E04C-4944-A440-310B8388DEEF</gtr:id><gtr:name>Hospital Pedi?trico David Bernardino</gtr:name></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.rcuk.ac.uk:80/organisation/091A7281-194A-4C7B-8E9A-0CEB4FEE954B"><gtr:id>091A7281-194A-4C7B-8E9A-0CEB4FEE954B</gtr:id><gtr:name>Faculty of Medicine</gtr:name></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:department>Dept of Medicine</gtr:department><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB"><gtr:id>1C4A24DC-2FF4-47B7-B5FA-46BFF24DF5AB</gtr:id><gtr:name>National Institute for Medical Research</gtr:name><gtr:address><gtr:line1>Ocean Road</gtr:line1><gtr:line2>PO Box 9653</gtr:line2><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/F11E21C9-E05F-4173-939C-61F868FE1FBA"><gtr:id>F11E21C9-E05F-4173-939C-61F868FE1FBA</gtr:id><gtr:name>The Wellcome Trust Ltd</gtr:name><gtr:address><gtr:line1>215 Euston Road</gtr:line1><gtr:line4>London</gtr:line4><gtr:postCode>NW1 2BE</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E9066440-7923-4DA5-9C32-D4A1055C7DA6"><gtr:id>E9066440-7923-4DA5-9C32-D4A1055C7DA6</gtr:id><gtr:name>Cipla</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/9218106A-E8CE-46A5-AABC-B4C8ED148690"><gtr:id>9218106A-E8CE-46A5-AABC-B4C8ED148690</gtr:id><gtr:name>University of Amsterdam</gtr:name><gtr:address><gtr:line1>Liaison Office</gtr:line1><gtr:line2>PO Box 19268</gtr:line2><gtr:line4>Amsterdam</gtr:line4><gtr:line5>Amsterdam</gtr:line5><gtr:postCode>1000 GG</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/ABE644D6-BBB8-44F3-96AA-6F49F0964577"><gtr:id>ABE644D6-BBB8-44F3-96AA-6F49F0964577</gtr:id><gtr:name>KEMRI-Wellcome Trust Research Programme</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/885DF811-29D2-42F7-AB4C-5857ED774495"><gtr:id>885DF811-29D2-42F7-AB4C-5857ED774495</gtr:id><gtr:name>Mbale Regional Hospital</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/1CD49681-075D-4AB9-A644-ED328E7C8D3A"><gtr:id>1CD49681-075D-4AB9-A644-ED328E7C8D3A</gtr:id><gtr:name>Malaria Consortium Africa, Kampala</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/5B1DAD82-5850-4A1E-8E7C-848FBC0A8F82"><gtr:id>5B1DAD82-5850-4A1E-8E7C-848FBC0A8F82</gtr:id><gtr:name>Spectral Diagnostics Inc</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/8446A993-B4C4-4CF7-8C31-B7F7566AA246"><gtr:id>8446A993-B4C4-4CF7-8C31-B7F7566AA246</gtr:id><gtr:name>University of Malawi</gtr:name><gtr:address><gtr:line1>P.O. Box 278</gtr:line1><gtr:line4>Zomba</gtr:line4><gtr:region>Outside UK</gtr:region><gtr:country>Malawi</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/76119A17-D4F8-4258-80F0-C8B307FFFA52"><gtr:id>76119A17-D4F8-4258-80F0-C8B307FFFA52</gtr:id><gtr:name>Radboud University Nijmegen</gtr:name><gtr:address><gtr:line1>Radboud University Nijmegen</gtr:line1><gtr:line2>PO Box 9102</gtr:line2><gtr:line4>Nijmegen</gtr:line4><gtr:postCode>6500 HC</gtr:postCode><gtr:region>Outside UK</gtr:region><gtr:country>Netherlands</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/E46289C2-E04C-4944-A440-310B8388DEEF"><gtr:id>E46289C2-E04C-4944-A440-310B8388DEEF</gtr:id><gtr:name>Hospital Pedi?trico David Bernardino</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/3ED60B49-9C2B-4D71-B644-96CCC7F10194"><gtr:id>3ED60B49-9C2B-4D71-B644-96CCC7F10194</gtr:id><gtr:name>Liverpool School of Tropical Medicine</gtr:name><gtr:address><gtr:line1>School Of Tropical Medicine</gtr:line1><gtr:line2>Pembroke Place</gtr:line2><gtr:postCode>L3 5QA</gtr:postCode><gtr:region>Unknown</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.rcuk.ac.uk:80/organisation/091A7281-194A-4C7B-8E9A-0CEB4FEE954B"><gtr:id>091A7281-194A-4C7B-8E9A-0CEB4FEE954B</gtr:id><gtr:name>Faculty of Medicine</gtr:name><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/6002F9A6-73EA-4309-9E5B-76549A8111ED"><gtr:id>6002F9A6-73EA-4309-9E5B-76549A8111ED</gtr:id><gtr:firstName>Kalifa</gtr:firstName><gtr:otherNames>Abubakr</gtr:otherNames><gtr:surname>Bojang</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/86F8EE81-4F1B-447D-A0DF-9B291124FF81"><gtr:id>86F8EE81-4F1B-447D-A0DF-9B291124FF81</gtr:id><gtr:firstName>Michael</gtr:firstName><gtr:surname>Levin</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/055E355D-958F-4C26-AC0A-CC8A5F99E17B"><gtr:id>055E355D-958F-4C26-AC0A-CC8A5F99E17B</gtr:id><gtr:firstName>Charles</gtr:firstName><gtr:otherNames>Richard</gtr:otherNames><gtr:surname>Newton</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/58B69503-B9E3-43E3-AEB2-82D521E4C95E"><gtr:id>58B69503-B9E3-43E3-AEB2-82D521E4C95E</gtr:id><gtr:firstName>Diana</gtr:firstName><gtr:surname>Gibb</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/3A420A00-1701-481B-84A0-D803FBD9B19E"><gtr:id>3A420A00-1701-481B-84A0-D803FBD9B19E</gtr:id><gtr:firstName>Tsiri</gtr:firstName><gtr:surname>Agbenyega</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/A6BAEC07-E057-4F0A-933A-BF3E851B5C99"><gtr:id>A6BAEC07-E057-4F0A-933A-BF3E851B5C99</gtr:id><gtr:firstName>Abdel</gtr:firstName><gtr:otherNames>Ghayoum</gtr:otherNames><gtr:surname>Babiker</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/517859F3-C0C5-41DF-8646-8DBFE133C326"><gtr:id>517859F3-C0C5-41DF-8646-8DBFE133C326</gtr:id><gtr:firstName>Jennifer</gtr:firstName><gtr:surname>Evans</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/77BFBA36-5CEE-4975-8650-2C0A2EF6D4F7"><gtr:id>77BFBA36-5CEE-4975-8650-2C0A2EF6D4F7</gtr:id><gtr:firstName>Kathryn</gtr:firstName><gtr:surname>Maitland</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.rcuk.ac.uk:80/person/23D47341-B294-4027-B1ED-1C5C81B5B51E"><gtr:id>23D47341-B294-4027-B1ED-1C5C81B5B51E</gtr:id><gtr:firstName>Sarah</gtr:firstName><gtr:otherNames>Louise</gtr:otherNames><gtr:surname>Rowland-Jones</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.rcuk.ac.uk:80/projects?ref=G0601027"><gtr:id>B6ACCF48-A6F2-4D48-9BB2-34D90D54EFEF</gtr:id><gtr:title>Fluid Expansion As Supportive Therapy in critically ill African children (FEAST)</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601027</gtr:grantReference><gtr:abstractText>FEAST trial is a large randomised controlled trial in African children with severe illness examining whether the addition of rapid fluid infusion at hospital admission to standard case management improves survival compared to standard management alone. 
In sub-Saharan Africa case fatality rates in hospital for severe infections in children remains at 15-30%. In this region well over a million children die of severe infection in hospital each year. Currently, antimalarial and antimicrobial drugs are the mainstay of treatment, however most deaths occur early, due to the complications of severe illness, and before definitive treatments have time to act. In this situation doctors have to rely upon supportive therapies to treat complications to try to improve outcome. Defining which are the best life-saving treatments has been frustrated by the lack of clinical studies. 
Rapid fluid infusion to correct fluid deficits is a standard supportive treatment and practised routinely for the emergency management of children with severe illness. Currently, reticence to adopt this approach remains and thus in African hospitals children are managed with little fluid or no additional fluid. If the benefits of rapid fluid infusion were shown, then FEAST trial could potentially save thousands of lives of young children annually.</gtr:abstractText><gtr:technicalSummary>Over a million children are estimated to die from severe malaria annually, with most deaths occurring in African children under 5 years of age. Despite the availability of effective antimalarial drugs, 20-30% of children admitted to hospital with severe malaria die, usually within the first 24 hours following admission. Reduction in the early in-hospital mortality from severe childhood malaria in Africa is likely to depend on the application of simple interventions to correct the disordered physiology leading to death.

Correction of fluid deficits by rapid infusion (volume expansion) is practised routinely for sick children presenting for emergency care and would be a logical supportive treatment for children with severe malaria with signs of dehydration or shock. There is no consensus regarding best practice in this situation. Clinical management varies across Africa, some centres restricting fluids to maintenance only, while others administer whole blood, despite concerns regarding cost and the risks of transfusion-acquired infection. Haemodynamic studies have recently established that hypovolaemia is common in children with malaria complicated by acidosis, and the results of three trials indicate that volume expansion, particularly with albumin, is associated with a lower mortality than that observed using maintenance fluids alone. However, opinion on this perspective remains divided, and the current WHO guidelines are unclear on the extent, importance and required treatments for the volume deficits. 

To resolve this uncertainty we aim to establish definitively, through a multicentre, partially masked, randomised controlled trial, whether volume expansion using either saline or albumin results in a lower mortality than low volume maintenance fluids only (the current standard practise in most hospitals) in 1650 children with severe malaria complicated by acidosis. Interventions will be administered within 2 hours of admission. Mortality will be the primary outcome. Secondary outcomes will include adverse events (development of decompensated shock, pulmonary oedema or signs of raised intracranial pressure) and residual neurological deficits assessed at discharge and at 6 months. 

As the study will be conducted at three sites in Africa, with different malaria endemicity, using largely bedside criteria to enrol children, the results of the trial will be generalisable and as such would form the basis for future international treatment recommendations. Furthermore a cost-effectiveness analysis will be undertaken, comparing each of the two interventions with conventional treatment, which will enable future policy decisions to be based on firm economic data.</gtr:technicalSummary><gtr:fund><gtr:end>2010-11-13</gtr:end><gtr:funder url="http://gtr.rcuk.ac.uk:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-11-14</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>1751451</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Spectral Diagnostics Inc</gtr:collaboratingOrganisation><gtr:country>Canada</gtr:country><gtr:description>Targeting Anti-microbiological treatment in African children with Severe Malaria (TABS)</gtr:description><gtr:id>62E662A4-D859-4FA9-BC78-D8ACED69EAD8</gtr:id><gtr:impact>Submission to EDCTP- not funded
Preparation of grant for 2013</gtr:impact><gtr:partnerContribution>Development of study protocol

Industry Donations of product for free (Azithromycin and placebo) and/or diagnostics</gtr:partnerContribution><gtr:piContribution>Development of early phase trial of antimicrobial treatment- submitted to EDCTP and now to submit to MRC</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Amsterdam</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Paediatrics</gtr:department><gtr:description>TRACT trial :A randomised controlled trial of transfusion and treatment of severe anaemia in African children</gtr:description><gtr:id>9D86D61D-73BB-4939-B418-7A4473122617</gtr:id><gtr:impact>Submission of an expression of interest to MRC which has been approved by the Global Health Strategy Board for full submission in March 2011.</gtr:impact><gtr:partnerContribution>Trial design Trial design</gtr:partnerContribution><gtr:piContribution>Our group have identified that transfusion of African children is a research and treatment priority. We have brought together a number of experts in the field of transfusion and severe anaemia to review the evidence for a transfusion trial and develop a research agenda for this area critical to management of severely-ill children in Africa including a trial which incorporates a factorial design.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>KEMRI-Wellcome Trust Research Programme</gtr:department><gtr:description>Uganda Blood Transfusion</gtr:description><gtr:id>4F44AD88-443B-4D5A-B3C3-AB6D97B09A38</gtr:id><gtr:impact>TRACT trial protocol approval in Uganda
Trial started enrolment in Sept 2013</gtr:impact><gtr:partnerContribution>Blood transfusion services will be critical in this collaboration for the successful conduct of the transfusion componant of the TRACT trial</gtr:partnerContribution><gtr:piContribution>For the purposes of the FEAST and TRACT trial developed new network of clinical trial sites</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Paediatrics</gtr:department><gtr:description>Uganda Blood Transfusion</gtr:description><gtr:id>4BF5B8E0-7DBE-4029-A441-8A32D8473BE9</gtr:id><gtr:impact>TRACT trial protocol approval in Uganda
Trial started enrolment in Sept 2013</gtr:impact><gtr:partnerContribution>Blood transfusion services will be critical in this collaboration for the successful conduct of the transfusion componant of the TRACT trial</gtr:partnerContribution><gtr:piContribution>For the purposes of the FEAST and TRACT trial developed new network of clinical trial sites</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Cipla</gtr:collaboratingOrganisation><gtr:country>India, Republic of</gtr:country><gtr:description>Targeting Anti-microbiological treatment in African children with Severe Malaria (TABS)</gtr:description><gtr:id>B4F4E57D-DE9A-4E86-8DAB-287157A258EA</gtr:id><gtr:impact>Submission to EDCTP- not funded
Preparation of grant for 2013</gtr:impact><gtr:partnerContribution>Development of study protocol

Industry Donations of product for free (Azithromycin and placebo) and/or diagnostics</gtr:partnerContribution><gtr:piContribution>Development of early phase trial of antimicrobial treatment- submitted to EDCTP and now to submit to MRC</gtr:piContribution><gtr:sector>Private</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>Thailand, Kingdom of</gtr:country><gtr:department>Mahidol University-Oxford Tropical Medicine Research Programme</gtr:department><gtr:description>SMAART consortium</gtr:description><gtr:id>5E549D80-BF37-4DE1-93D8-C765E9264CD0</gtr:id><gtr:impact>none yet; meeting planned for June 2016 to plan the grant submission to UK funder collaborative award</gtr:impact><gtr:partnerContribution>To overcome the barriers to achieving this goal, SMAART brings together applicants and co-investigators from three Wellcome Trust major overseas programmes (KEMRI Wellcome Trust Programme, Kenya, Malawi-Liverpool-Wellcome Trust Unit, Malawi (Prof David Lalloo) and Mahidol Oxford Research Unit, Thailand together with African scientists from existing or new collaborations and specialists in clinical trials ( MRC CTU at UCL) and ultimately national and international stakeholders. All are necessary to ensure that the most important questions are identified and combined optimally in the most efficient trial design which is acceptable and relevant to parents, healthcare professionals, ethical review boards and ministries of health. The network is thus a multi-disciplinary team providing complementary expertise and added value including links to other networks. The SMAART consortium encompasses decades of clinical and academic experience, track records of successful high quality research in low-income settings, and significant impact as evidenced by publication citation, grant funding and policy change.</gtr:partnerContribution><gtr:piContribution>The main aim of SMAART is to conduct better research studies faster, to improve outcomes from severe malaria. SMAART will act as the operational platform by which future research is planned in a coordinated and reciprocal manner to continuously update disease definitions and treatment guidelines for severe malaria.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>KEMRI-Wellcome Trust Research Programme</gtr:department><gtr:description>Uganda Blood Transfusion</gtr:description><gtr:id>9C4DCCEA-534A-4F5F-A85D-9685285FC57C</gtr:id><gtr:impact>TRACT trial protocol approval in Uganda
Trial started enrolment in Sept 2013</gtr:impact><gtr:partnerContribution>Blood transfusion services will be critical in this collaboration for the successful conduct of the transfusion componant of the TRACT trial</gtr:partnerContribution><gtr:piContribution>For the purposes of the FEAST and TRACT trial developed new network of clinical trial sites</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>KEMRI-Wellcome Trust Research Programme</gtr:department><gtr:description>Medicine Sans Frontiere</gtr:description><gtr:id>C65417B5-A8E5-43CC-82BB-3759F946A6C8</gtr:id><gtr:impact>Clinical studies on going in Kenya/Uganda

Multidisplinary: clinical trials, critical care, humanitarian health</gtr:impact><gtr:partnerContribution>Protocol development and cofunding for clinical trial</gtr:partnerContribution><gtr:piContribution>Design of fluid management studies in severe malnutrition</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Radboud University Nijmegen</gtr:collaboratingOrganisation><gtr:country>Netherlands, Kingdom of the</gtr:country><gtr:department>Department of Pharmacology and Toxicology</gtr:department><gtr:description>Targeting Anti-microbiological treatment in African children with Severe Malaria (TABS)</gtr:description><gtr:id>0B9B0B1C-271E-4372-BA91-9DAD58C4CA5A</gtr:id><gtr:impact>Submission to EDCTP- not funded
Preparation of grant for 2013</gtr:impact><gtr:partnerContribution>Development of study protocol

Industry Donations of product for free (Azithromycin and placebo) and/or diagnostics</gtr:partnerContribution><gtr:piContribution>Development of early phase trial of antimicrobial treatment- submitted to EDCTP and now to submit to MRC</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>Malawi, Republic of</gtr:country><gtr:department>Malawi-Liverpool Wellcome Trust Clinical Research Programme</gtr:department><gtr:description>SMAART consortium</gtr:description><gtr:id>106E761C-F59C-439B-A97B-C7B9EF0CB6C0</gtr:id><gtr:impact>none yet; meeting planned for June 2016 to plan the grant submission to UK funder collaborative award</gtr:impact><gtr:partnerContribution>To overcome the barriers to achieving this goal, SMAART brings together applicants and co-investigators from three Wellcome Trust major overseas programmes (KEMRI Wellcome Trust Programme, Kenya, Malawi-Liverpool-Wellcome Trust Unit, Malawi (Prof David Lalloo) and Mahidol Oxford Research Unit, Thailand together with African scientists from existing or new collaborations and specialists in clinical trials ( MRC CTU at UCL) and ultimately national and international stakeholders. All are necessary to ensure that the most important questions are identified and combined optimally in the most efficient trial design which is acceptable and relevant to parents, healthcare professionals, ethical review boards and ministries of health. The network is thus a multi-disciplinary team providing complementary expertise and added value including links to other networks. The SMAART consortium encompasses decades of clinical and academic experience, track records of successful high quality research in low-income settings, and significant impact as evidenced by publication citation, grant funding and policy change.</gtr:partnerContribution><gtr:piContribution>The main aim of SMAART is to conduct better research studies faster, to improve outcomes from severe malaria. SMAART will act as the operational platform by which future research is planned in a coordinated and reciprocal manner to continuously update disease definitions and treatment guidelines for severe malaria.</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2015-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Liverpool School of Tropical Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>TRACT trial :A randomised controlled trial of transfusion and treatment of severe anaemia in African children</gtr:description><gtr:id>D63A53C0-5437-432E-BACE-79FCA323D1B8</gtr:id><gtr:impact>Submission of an expression of interest to MRC which has been approved by the Global Health Strategy Board for full submission in March 2011.</gtr:impact><gtr:partnerContribution>Trial design Trial design</gtr:partnerContribution><gtr:piContribution>Our group have identified that transfusion of African children is a research and treatment priority. We have brought together a number of experts in the field of transfusion and severe anaemia to review the evidence for a transfusion trial and develop a research agenda for this area critical to management of severely-ill children in Africa including a trial which incorporates a factorial design.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Hospital Pedi?trico David Bernardino</gtr:collaboratingOrganisation><gtr:country>Angola, Republic of</gtr:country><gtr:department>Department of Paediatrics</gtr:department><gtr:description>TRACT trial :A randomised controlled trial of transfusion and treatment of severe anaemia in African children</gtr:description><gtr:id>0EA26383-181B-4BF9-97D9-4D943D3286E9</gtr:id><gtr:impact>Submission of an expression of interest to MRC which has been approved by the Global Health Strategy Board for full submission in March 2011.</gtr:impact><gtr:partnerContribution>Trial design Trial design</gtr:partnerContribution><gtr:piContribution>Our group have identified that transfusion of African children is a research and treatment priority. We have brought together a number of experts in the field of transfusion and severe anaemia to review the evidence for a transfusion trial and develop a research agenda for this area critical to management of severely-ill children in Africa including a trial which incorporates a factorial design.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>The Wellcome Trust Ltd</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>KEMRI-Wellcome Trust Research Programme</gtr:department><gtr:description>Medical Research Council Clinical Trials Unit</gtr:description><gtr:id>27D318CE-D826-4FF7-977F-8999FEDE7659</gtr:id><gtr:impact>FEAST trial 
Publications 
Alexander Fleming Award
TRACT trial</gtr:impact><gtr:partnerContribution>Design of clinical trials, trial governance and data management, statatistical expertise

Multidisciplinary clinical trialists, infectious disease speacialists, health economists and specialists in health policy</gtr:partnerContribution><gtr:piContribution>Work leading up the trials, identification of partners, trial sites and design and execution of clinical trials</gtr:piContribution><gtr:sector>Multiple</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Paediatrics</gtr:department><gtr:description>Medical Research Council Clinical Trials Unit</gtr:description><gtr:id>5609CEFB-9118-4173-8F2D-2DF2823FCC07</gtr:id><gtr:impact>FEAST trial 
Publications 
Alexander Fleming Award
TRACT trial</gtr:impact><gtr:partnerContribution>Design of clinical trials, trial governance and data management, statatistical expertise

Multidisciplinary clinical trialists, infectious disease speacialists, health economists and specialists in health policy</gtr:partnerContribution><gtr:piContribution>Work leading up the trials, identification of partners, trial sites and design and execution of clinical trials</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Mbale Regional Hospital</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:description>Mbale and Soroti Hospitals- Wellcome Trust Collaboration</gtr:description><gtr:id>274DA9D3-5FC9-4478-9AA7-10EF14D28EA2</gtr:id><gtr:impact>Routine clinical surveillance is due to be introduced and already a number of sub studies of life threatening childhood infections within FEAST have provided collaborative links with the KEMRI Wellcome Trust Programme. These include studies of pathogenesis (immunology and pathogen biology groups), evaluation of community perceptions of the consent process developed for FEAST, case control genetic studies and new biomarkers for severe malaria. A number of these studies are being conducted by the PI from Mbale who is registered on KEMRI Open University PhD programme.</gtr:impact><gtr:partnerContribution>Development of a clinical research team and undertaken a number of substudies
A new laboratory will be built in the 2104, supported by Imperial College</gtr:partnerContribution><gtr:piContribution>These previously research na&amp;iuml;ve hospitals were brought into the FEAST trial by the PI working in parntership with Malaria Consortium, Uganda. The site PIs have worked with the FEAST team to develop a clinical research platform to study acute malaria, which remains the major cause of admission. Comparative studies with Kilifi offer new potential insights into disease pathogenesis.</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Faculty of Medicine</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>Department of Medicine</gtr:department><gtr:description>Mbale and Soroti Hospitals- Wellcome Trust Collaboration</gtr:description><gtr:id>08B7BC93-08F1-44B5-80E4-FCB4380BE199</gtr:id><gtr:impact>Routine clinical surveillance is due to be introduced and already a number of sub studies of life threatening childhood infections within FEAST have provided collaborative links with the KEMRI Wellcome Trust Programme. These include studies of pathogenesis (immunology and pathogen biology groups), evaluation of community perceptions of the consent process developed for FEAST, case control genetic studies and new biomarkers for severe malaria. A number of these studies are being conducted by the PI from Mbale who is registered on KEMRI Open University PhD programme.</gtr:impact><gtr:partnerContribution>Development of a clinical research team and undertaken a number of substudies
A new laboratory will be built in the 2104, supported by Imperial College</gtr:partnerContribution><gtr:piContribution>These previously research na&amp;iuml;ve hospitals were brought into the FEAST trial by the PI working in parntership with Malaria Consortium, Uganda. The site PIs have worked with the FEAST team to develop a clinical research platform to study acute malaria, which remains the major cause of admission. Comparative studies with Kilifi offer new potential insights into disease pathogenesis.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Trials Unit</gtr:department><gtr:description>Uganda Blood Transfusion</gtr:description><gtr:id>DDD70D4E-DB84-46E8-A417-709DEA9CAD70</gtr:id><gtr:impact>TRACT trial protocol approval in Uganda
Trial started enrolment in Sept 2013</gtr:impact><gtr:partnerContribution>Blood transfusion services will be critical in this collaboration for the successful conduct of the transfusion componant of the TRACT trial</gtr:partnerContribution><gtr:piContribution>For the purposes of the FEAST and TRACT trial developed new network of clinical trial sites</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Clinical Trials Unit</gtr:department><gtr:description>Targeting Anti-microbiological treatment in African children with Severe Malaria (TABS)</gtr:description><gtr:id>7843D53B-B13F-4B47-A761-004935573B40</gtr:id><gtr:impact>Submission to EDCTP- not funded
Preparation of grant for 2013</gtr:impact><gtr:partnerContribution>Development of study protocol

Industry Donations of product for free (Azithromycin and placebo) and/or diagnostics</gtr:partnerContribution><gtr:piContribution>Development of early phase trial of antimicrobial treatment- submitted to EDCTP and now to submit to MRC</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2012-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Malaria Consortium Africa, Kampala</gtr:collaboratingOrganisation><gtr:country>Uganda, Republic of</gtr:country><gtr:description>Malaria Consortium_ FEAST trial extension</gtr:description><gtr:id>DC44DAD2-2EB6-4982-B8EB-52EC34E64DA6</gtr:id><gtr:impact>Extension of FEAST trial (G0801439)
Setting up of 3 new trial sties for research- required a multi disciplinary team.</gtr:impact><gtr:partnerContribution>Hosting of the FEAST management team and monitors. Financial and logistic management of 4 trial sites</gtr:partnerContribution><gtr:piContribution>THe FEAST trial was re-located from Ghana, The Gambia to Uganda and Teule, Tanzania. Linking to 4 sites in Uganda was made possible through a new collaboration with Malaria Consortium in partnership with our research team. Collaborators and co applicant added to extension (GO801439).</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>KEMRI-Wellcome Trust Research Programme</gtr:collaboratingOrganisation><gtr:country>Kenya, Republic of</gtr:country><gtr:department>Genetic Haemoglobinopathy Group</gtr:department><gtr:description>Human Genetics</gtr:description><gtr:id>4B8889BB-1853-4CC1-AB63-1690CDEC88AA</gtr:id><gtr:impact>Laboratory strengthening at Mbale Regional Referral Hospital, Eastern Uganda
Multi-disciplinary: medical, immunology, molecular, genetics</gtr:impact><gtr:partnerContribution>Design of basic science investigation</gtr:partnerContribution><gtr:piContribution>Basic science investigation for FEAST trial and planned investigation in TRACT trial</gtr:piContribution><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2011-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>University of Malawi</gtr:collaboratingOrganisation><gtr:country>Malawi, Republic of</gtr:country><gtr:department>College of Medicine</gtr:department><gtr:description>TRACT trial :A randomised controlled trial of transfusion and treatment of severe anaemia in African children</gtr:description><gtr:id>391F1AF0-AF61-45A5-A39B-520ED24D0B63</gtr:id><gtr:impact>Submission of an expression of interest to MRC which has been approved by the Global Health Strategy Board for full submission in March 2011.</gtr:impact><gtr:partnerContribution>Trial design Trial design</gtr:partnerContribution><gtr:piContribution>Our group have identified that transfusion of African children is a research and treatment priority. We have brought together a number of experts in the field of transfusion and severe anaemia to review the evidence for a transfusion trial and develop a research agenda for this area critical to management of severely-ill children in Africa including a trial which incorporates a factorial design.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>National Institute for Medical Research, Tanzania</gtr:collaboratingOrganisation><gtr:country>Tanzania, United Republic of</gtr:country><gtr:department>Teule Hospital</gtr:department><gtr:description>NIMRI, Teule, Tanzania</gtr:description><gtr:id>ACEA63F5-C1CC-4D6B-8D54-8381D0E0C866</gtr:id><gtr:impact>FEAST trial site</gtr:impact><gtr:partnerContribution>Teule Hospital, through NIMRI joined the FEAST trial</gtr:partnerContribution><gtr:piContribution>Relocation of FEAST to 5 new sites in East AFrica and resubmission of extension (GO801439) with coapplicants from NIMRI</gtr:piContribution><gtr:sector>Hospitals</gtr:sector><gtr:start>2007-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Radio_Interview BBC</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>D6F44915-EEDF-4471-A288-723704FB5330</gtr:id><gtr:impact>In 2015 I was interviewed for BBC World Service Life Changers by Kevin Fong (Discovery-20150831-LifeChangersKathrynMaitland.mp3)</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.bbc.co.uk/programmes/p030mb5n</gtr:url><gtr:year>2015</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Meeting of African Paediatricians to review fluid resuscitation management policy fo</gtr:description><gtr:form>Participation in an activity, workshop or similar</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>1270EB99-5D0A-4334-B317-332B63B3C9AC</gtr:id><gtr:impact>A meeting was held in Nairobi, 12th-13th October 2012, to examine the evidence on the use of boluses (rapid fluid resuscitation) for critically sick children in sub-Saharan Africa, and consider the implications of this evidence. The meeting was hosted by the Kenya Paediatric Association, and was attended by paediatricians and other healthcare personnel and researchers from 10 sub-Saharan African countries, as well as members of the FEAST trial team from Africa.

A meta-analysis of all the available evidence on fluid resuscitation for these children was carried out subsequently and has been published; it supports the conclusions of the FEAST trial (see http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0043953).

This delegates agreed that the new evidence presented means that international and national guidelines, policy and practice need to change. The recommendations should no longer be that children with febrile illness (due to malaria and/or sepsis including presumptive diagnoses) and impaired perfusion, and/or impaired consciousness and/or respiratory distress should be given fluid boluses (ie giving fluids rapidly over a short period of time). Instead it should be recommended that maintenance fluids should be given slowly at 4ml/hour to replace fluid losses.

A number of hospitals (including those involved in the trial) and Medicins Sans Frontiers have already changed their practice in the light of these results, but other international and national organisations and institutions have been slower to change, due in part to lack of guidance from the World Health Organisation.

At the conclusion of the workshop the delegates indicated that it was clear to them from the published evidence and further discussions of evidence presented at the meeting that international (WHO) and national guidelines, policy and practice need to change.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:presentationType>Workshop Facilitator</gtr:presentationType><gtr:primaryAudience>Health professionals</gtr:primaryAudience><gtr:url>http://www.plosone.org/article/info%3Adoi%2F10.1371%2Fjournal.pone.0043953</gtr:url><gtr:year>2012</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Interviewed by Voice of America about NEJM Severe Malaria Perspective</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>54C5DF50-94B2-4CB1-A288-A9611DA7BC8D</gtr:id><gtr:impact>New England Journal Perspective on Severe Malaria in African Children: need for continuing investment. I discussed the slow pace of progress in clinical trials in Africa; yet 10% of children with severe malaria will die. In the drive to eliminate malaria most scientists and policy makers felt that malaria was all but conquered. Many expressed surprise at the burden of disease. Thought published only on 22nd December 2016 the current Altmetrics for this article is 124.</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Media (as a channel to the public)</gtr:primaryAudience><gtr:url>http://www.voanews.com/a/death-toll-from-malaria-among-african-children-called-unacceptably-high/3665459.html</gtr:url><gtr:year>2017</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Consultation: Nuffield Council on Bioethics</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>E0321E05-A18E-42BF-A5FC-77102506DAB2</gtr:id><gtr:impact>I was asked to provide my views for Nuffield Council on Bioethics ahead of their consultation on ethical issues arising out of children's involvement in clinical research.

this has not yet happened</gtr:impact><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2013</gtr:year></gtr:disseminationOutput><gtr:disseminationOutput><gtr:description>Visit to WHO</gtr:description><gtr:form>A formal working group, expert panel or dialogue</gtr:form><gtr:geographicReach>International</gtr:geographicReach><gtr:id>20BFB3F3-D1BE-4021-A733-03BE1CEC7655</gtr:id><gtr:impact>WHO have the full results of trial (published and unpublished) as well as policy brief.
They are currently conducting a review of the evidence before the consider changing their guidelines

WHO are the key policy maker who advise on guidelines for management of children in LED countries including Africa. FEAST will direct inform policy 

WHO not yet changed policy further meeting with study investigators in 2012</gtr:impact><gtr:partOfOfficialScheme>true</gtr:partOfOfficialScheme><gtr:primaryAudience>Policymakers/parliamentarians</gtr:primaryAudience><gtr:year>2010,2012</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1500000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Major Overseas Programme Grant</gtr:description><gtr:end>2021-09-02</gtr:end><gtr:fundingOrg>The Wellcome Trust Ltd</gtr:fundingOrg><gtr:fundingRef>203077/Z/16/Z</gtr:fundingRef><gtr:id>5091D2A2-BA4D-48FB-AE51-50A8C0FC7072</gtr:id><gtr:sector>Charity/Non Profit</gtr:sector><gtr:start>2016-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>30000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Alexander Flemming Dissemination Grant</gtr:description><gtr:end>2013-11-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>C0395</gtr:fundingRef><gtr:id>B886629F-9240-4D31-9B9B-05E5E678BDA1</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2012-11-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>2747308</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>Global Health Trials</gtr:description><gtr:end>2011-07-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:fundingRef>G0801439</gtr:fundingRef><gtr:id>95BA999B-F7EE-4DB0-9DA8-2AB8DA2907C9</gtr:id><gtr:sector>Academic/University</gtr:sector><gtr:start>2008-07-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHO 2014 severe malaria guidelines</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:guidelineTitle>Severe Malaria</gtr:guidelineTitle><gtr:id>91A240F2-ED00-491A-A856-B2BD95D5C41B</gtr:id><gtr:impact>Fluid resuscitation is not longer recommended for children with severe malaria- leading to the saving of many lives worldwide.</gtr:impact><gtr:type>Citation in clinical guidelines</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/25214480</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Consensus Round Table Symposium on Fluid resuscitation</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>7C947035-50C8-4C41-BB2F-EB3C9AF78017</gtr:id><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Fluid resuscitation in children</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>AE81DB15-6C64-49FD-86BA-247EA9DF808B</gtr:id><gtr:impact>Medicine Sans Frontieres commissioned this review and changed their treatment guidelines for fluid resuscitation in children</gtr:impact><gtr:type>Citation in systematic reviews</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/22952819</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>East Africa Guidelines Panel Recommendations</gtr:description><gtr:geographicReach>Africa</gtr:geographicReach><gtr:guidelineTitle>Draft recommendations for management of children with severe febrile illness and impaired circulation without signs of severely impaired circulation</gtr:guidelineTitle><gtr:id>A528A999-107E-43B1-95FA-E9716C06D957</gtr:id><gtr:type>Citation in clinical guidelines</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in Review of Resuscitation Fluids in NEJM</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>9A74FF1A-44CB-4BE0-AD2B-5BC587E747F2</gtr:id><gtr:type>Citation in clinical reviews</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/24350966</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Acute Dialysis Quality Initiative (ADQI) consensus conference Fluid management in critical illness</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>57B31A1B-0481-4295-8899-B13510BD2AF5</gtr:id><gtr:impact>The delegates of the 12th Acute Dialysis Quality Initiative (ADQI) Conference sought to obtain consensus on the use of i.v. fluids with the aim of producing guidance for their use. The reviewed a recently proposed model for fluid therapy in severe sepsis and propose a framework by which it could be adopted for use in most situations where fluid management is required. Considering the dose-effect relationship and side-effects of fluids, fluid therapy should be regarded similar to other drug therapy with specific indications and tailored recommendations for the type and dose of fluid. By emphasizing the necessity to individualize fluid therapy, we hope to reduce the risk to our patients and improve their outcome</gtr:impact><gtr:type>Participation in advisory committee</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/25204700</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Systematic Review of Fluid resuscitation in children</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>C0F2795E-52CC-4E39-853E-41A67642C301</gtr:id><gtr:impact>Medicine Sans Frontiere changed guidelines</gtr:impact><gtr:type>Citation in systematic reviews</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Citation in 'A critique of fluid bolus resuscitation in severe sepsis'</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>FD78AE0C-4397-4811-87E8-7E72BACB933F</gtr:id><gtr:type>Citation in clinical reviews</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/22277834</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Membership of Technical Expert Group for Severe Malaria</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>44E15008-6ECA-4667-84B6-1D810132F99C</gtr:id><gtr:impact>Fluid management of severe malaria in children has been informed by the publication of the FESAT trial. The TEG is currently (Nov 2013) undertaking a revision of management guidelines (to be published in 2015). WHO will consider recommendation made by this review committee whilst revising current guidelines.</gtr:impact><gtr:type>Participation in advisory committee</gtr:type></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>WHOETAT: Management of Severe Illness in Resource-poor hospitals</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>167FBA9D-C96C-4942-AB91-10D7018962CE</gtr:id><gtr:type>Membership of a guidance committee</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/24462328</gtr:url></gtr:policyInfluenceOutput><gtr:policyInfluenceOutput><gtr:areas/><gtr:description>Multiple Commentaries and Reviews of FEAST trial result</gtr:description><gtr:geographicReach>Multiple continents/international</gtr:geographicReach><gtr:id>5E645F1E-D0C1-4A20-9B2F-12299C462EDA</gtr:id><gtr:type>Citation in clinical reviews</gtr:type></gtr:policyInfluenceOutput></gtr:policyInfluenceOutputs><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs><gtr:researchDatabaseAndModelOutput><gtr:description>Open Clinica was used a platform for this database</gtr:description><gtr:id>AE564B96-E213-463B-B208-F60403E6E620</gtr:id><gtr:impact>Multiple papers have resulted from this database, and has feed into chapters in at least 2 Phds. The database will eventually become open access</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>FEAST trial database</gtr:title><gtr:type>Database/Collection of data</gtr:type></gtr:researchDatabaseAndModelOutput></gtr:researchDatabaseAndModelOutputs><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>Open Clinica an open source database software that was specifically adapted for use in this trial by our programmer/data manager</gtr:description><gtr:id>62FEA89E-1EF4-418B-AC85-A9A60730C872</gtr:id><gtr:impact>Wider appreciation that open source software can be used as a platform for GCP trial and is compliant with FDA standards</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Development of Open Clinica for multisite trial</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/21453454</gtr:url></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>FEAST is the largest Phase III paediatric fluid resuscitation trial ever undertaken. To ensure an ethical and humane process to approaching parents- we developed a novel strategy for deferred consent. We were uncomfortable with full consent waiver since this may mean that parents may never get to know that their child was involved in a research study - which if they had known at the time of admission they could have exercised their right to refuse. For the sickest children we opted for, and have ethical approval for, parental verbal assent, where parents understood that their child would be involved in a clinical trial, but the details would be given after recruitment - during informed consent- once their child was stablised. We plan substudies to evaluate this with social sciences groups specializing in research ethics. Our methodology has been written up and recently submitted for publication.</gtr:description><gtr:id>21B4E5C5-FF31-4756-BCF9-2AB682F4AE3D</gtr:id><gtr:impact>The ethical landscape has changed so vastly such that any pragmatic consenting process giving the key sensitivities to parents so they can weigh up risks and benefits contextually is now a rare phenomenon. Having presented the FEAST trial at international paediatric critical care conferences and more recently in a meningitis meeting - our consent process was welcomed as practical and helpful example by paediatricians who are struggling with European ICH GCP legislation. There have been two important regulatory developments in recent years. Firstly, in January 2007 EU paediatric medicine regulation (Regulation (EC) No 1901/2006) requiring all new license applications to include paediatric data. Followed by the December 2006 amendment to the EU trials directive that was intended to enable research in emergencies. Recent reports suggest this is not working in practice. The new requirement for research in children is compounded by the lack of guidance for conducting studies in this setting. FEAST trial consent process therefore sets a benchmark for future paediatric trials.</gtr:impact><gtr:providedToOthers>false</gtr:providedToOthers><gtr:title>Pragmatic Deferred Consent Proceedure for research in emergency medicine</gtr:title><gtr:type>Improvements to research infrastructure</gtr:type><gtr:url>http://www.ncbi.nlm.nih.gov/pubmed/23408950</gtr:url></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8D411B57-3CD1-48B6-92AA-190E8A5EC25B"><gtr:id>8D411B57-3CD1-48B6-92AA-190E8A5EC25B</gtr:id><gtr:title>WHO guidelines on fluid resuscitation in children: missing the FEAST data.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a95726c6f6fe2073a4b03b81f5d7def1"><gtr:id>a95726c6f6fe2073a4b03b81f5d7def1</gtr:id><gtr:otherNames>Kiguli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/AB194CD3-BBA7-4E46-84DE-718F9BFFB5FA"><gtr:id>AB194CD3-BBA7-4E46-84DE-718F9BFFB5FA</gtr:id><gtr:title>WHO guidelines on fluid resuscitation in children: missing the FEAST data.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a95726c6f6fe2073a4b03b81f5d7def1"><gtr:id>a95726c6f6fe2073a4b03b81f5d7def1</gtr:id><gtr:otherNames>Kiguli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/37A8D2C3-7F0D-4151-A6C2-25265C9BDBF8"><gtr:id>37A8D2C3-7F0D-4151-A6C2-25265C9BDBF8</gtr:id><gtr:title>Strategies for efficient computation of the expected value of partial perfect information.</gtr:title><gtr:parentPublicationTitle>Medical decision making : an international journal of the Society for Medical Decision Making</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/13645c07a180a522f538980c4be6a5f6"><gtr:id>13645c07a180a522f538980c4be6a5f6</gtr:id><gtr:otherNames>Madan J</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0272-989X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0F5C1621-4D92-4784-A3A3-A9E522409A3A"><gtr:id>0F5C1621-4D92-4784-A3A3-A9E522409A3A</gtr:id><gtr:title>'The words will pass with the blowing wind': staff and parent views of the deferred consent process, with prior assent, used in an emergency fluids trial in two African hospitals.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/1ef4ca17df21fb85d5773d6b0068940b"><gtr:id>1ef4ca17df21fb85d5773d6b0068940b</gtr:id><gtr:otherNames>Molyneux S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/C91FB6BA-3665-492E-AFE8-A3CDF706DF4B"><gtr:id>C91FB6BA-3665-492E-AFE8-A3CDF706DF4B</gtr:id><gtr:title>Mortality after fluid bolus in African children with severe infection.</gtr:title><gtr:parentPublicationTitle>The New England journal of medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86eb93149109bb11bc7f076a9c50c2ab"><gtr:id>86eb93149109bb11bc7f076a9c50c2ab</gtr:id><gtr:otherNames>Maitland K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>0028-4793</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/DFCF1B6E-DEA5-406A-8454-49E5ACAD001D"><gtr:id>DFCF1B6E-DEA5-406A-8454-49E5ACAD001D</gtr:id><gtr:title>Endotoxaemia is common in children with Plasmodium falciparum malaria.</gtr:title><gtr:parentPublicationTitle>BMC infectious diseases</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/ed5b3cb32e7e2511144de37caf6e2d66"><gtr:id>ed5b3cb32e7e2511144de37caf6e2d66</gtr:id><gtr:otherNames>Olupot-Olupot P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1471-2334</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/9DC48D7F-8B18-40D8-9563-168AA8B8639B"><gtr:id>9DC48D7F-8B18-40D8-9563-168AA8B8639B</gtr:id><gtr:title>Use of deferred consent for severely ill children in a multi-centre phase III trial.</gtr:title><gtr:parentPublicationTitle>Trials</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86eb93149109bb11bc7f076a9c50c2ab"><gtr:id>86eb93149109bb11bc7f076a9c50c2ab</gtr:id><gtr:otherNames>Maitland K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1745-6215</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/7C79D7E3-DBA0-48C0-8BF9-6A41ADCFFD66"><gtr:id>7C79D7E3-DBA0-48C0-8BF9-6A41ADCFFD66</gtr:id><gtr:title>Exploring mechanisms of excess mortality with early fluid resuscitation: insights from the FEAST trial.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/86eb93149109bb11bc7f076a9c50c2ab"><gtr:id>86eb93149109bb11bc7f076a9c50c2ab</gtr:id><gtr:otherNames>Maitland K</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/8DC6A95B-DCB1-4D43-94FA-D372CE1669F1"><gtr:id>8DC6A95B-DCB1-4D43-94FA-D372CE1669F1</gtr:id><gtr:title>Anaemia and blood transfusion in African children presenting to hospital with severe febrile illness.</gtr:title><gtr:parentPublicationTitle>BMC medicine</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/a95726c6f6fe2073a4b03b81f5d7def1"><gtr:id>a95726c6f6fe2073a4b03b81f5d7def1</gtr:id><gtr:otherNames>Kiguli S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1741-7015</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/0AA13E47-BB83-4B41-B648-5255D602781F"><gtr:id>0AA13E47-BB83-4B41-B648-5255D602781F</gtr:id><gtr:title>Predicting the clinical outcome of severe falciparum malaria in african children: findings from a large randomized trial.</gtr:title><gtr:parentPublicationTitle>Clinical infectious diseases : an official publication of the Infectious Diseases Society of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/fedd129d241c35a3047bd96947e42660"><gtr:id>fedd129d241c35a3047bd96947e42660</gtr:id><gtr:otherNames>von Seidlein L</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>1058-4838</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/F3584DDA-22E4-4F52-B793-7851A8770EE6"><gtr:id>F3584DDA-22E4-4F52-B793-7851A8770EE6</gtr:id><gtr:title>Choice of fluids for resuscitation in children with severe infection and shock: systematic review.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d3de0e37cf6cf2c6803b51eeb31bf14d"><gtr:id>d3de0e37cf6cf2c6803b51eeb31bf14d</gtr:id><gtr:otherNames>Akech S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication><gtr:publication url="http://gtr.rcuk.ac.uk:80/publication/187BA0F2-82C0-47C5-ACD1-8E8426BBED03"><gtr:id>187BA0F2-82C0-47C5-ACD1-8E8426BBED03</gtr:id><gtr:title>Choice of fluids for resuscitation in children with severe infection and shock: systematic review.</gtr:title><gtr:parentPublicationTitle>BMJ (Clinical research ed.)</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.rcuk.ac.uk:80/person/d3de0e37cf6cf2c6803b51eeb31bf14d"><gtr:id>d3de0e37cf6cf2c6803b51eeb31bf14d</gtr:id><gtr:otherNames>Akech S</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>0959-535X</gtr:issn></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601027</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>03BA7BC9-C251-48FC-8EA9-5F7414A63FEE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Infection</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>7135039D-2DB0-4D41-87B3-FA1C8D38E133</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>6.1  Pharmaceuticals</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>